Results 11 to 20 of about 40,439 (247)

Does Timing of Initiation Influence Acceptance and Adherence to NIV in Patients With ALS?

open access: yesPulmonology, 2020
Background: The role of nocturnal non invasive ventilation (NIV) to prolong tracheostomy-free survival, is still controversial in amyotrophic lateral sclerosis (ALS) patients and the best timing to initiate NIV is unclear.
Michele Vitacca, Mara Paneroni
exaly   +5 more sources

Exploring clinicians’ beliefs and practices regarding Non-Invasive Ventilation devices: An international survey study

open access: yesJournal of Mechanical Ventilation, 2023
Introduction Non-invasive ventilation (NIV) has a significant role in supporting patients with respiratory failure with the goal of avoiding mechanical ventilation.
Kevin Benavente   +3 more
doaj   +1 more source

HIGH FLOW NASAL OXYGEN THERAPY (HFNO) IN OPPOSITION TO NON-INVASIVE MECHANICAL VENTILATION (NIV) ADVANTAGES, DISADVANTAGES AND THEIR USE IN COVID-19 INFECTION: BRIEF REVIEW

open access: yesSanamed, 2021
In the last few decades, different devices for oxygen application have become available, such as low flow systems, high flow systems (HFNO), and non-invasive ventilation (NIV). They are widely applicable and have many advantages as well as disadvantages.
Dmitrovic Radmila   +2 more
doaj   +1 more source

Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern

open access: yesEBioMedicine, 2022
Summary: Background: SARS-CoV-2 Omicron variant is rampantly spreading across the globe. We assessed the pathogenicity and immune response generated by BA.1.1 sub-lineage of SARS-CoV-2 [Omicron (R346K) variant] in 5 to 6-week old Syrian hamsters and ...
Sreelekshmy Mohandas   +10 more
doaj   +1 more source

Isolation of SARS-CoV-2 B.1.1.28.2 (P2) variant and pathogenicity comparison with D614G variant in hamster model

open access: yesJournal of Infection and Public Health, 2022
Background: Considering the potential threat from emerging Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2) variants and the rising COVID-19 cases, SARS-CoV-2 genomic surveillance is ongoing in India.
Pragya Yadav   +12 more
doaj   +1 more source

Home use of Non-invasive Ventilation for chronic obstructive pulmonary disease. Literature Review and update

open access: yesJournal of Mechanical Ventilation, 2021
Non-invasive ventilation use in acute COPD exacerbation and acute respiratory failure is very strong, however the evidence beyond home non-invasive ventilation for COPD patients is less clear.
Kimiyo Yamasaki
doaj   +1 more source

COVID-19 patients in myasthenic crisis managed successfully with noninvasive positive pressure ventilation: a case series.

open access: yesCritical Care Innovations, 2021
The management of respiratory failure during the present pandemic has been a challenging issue for the intensivists. There have been few case series and case reports on myasthenic crisis precipitated by severe acute respiratory syndrome coronavirus-2 ...
Mohd Mustahsin   +2 more
doaj   +1 more source

An outbreak of influenza A(H3N2) in Alappuzha district, Kerala, India, in 2011

open access: yesJournal of Infection in Developing Countries, 2015
Introduction: Influenza is an RNA virus that belongs to the Orthomyxoviridae family. It causes a highly contagious acute respiratory illness, has been recognized since ancient times, and is a major health threat throughout the world.
Sam Peter   +4 more
doaj   +1 more source

Guideline for the management of COVID-19 patients during hospital admission in a non-intensive care setting

open access: yesEuropean Clinical Respiratory Journal, 2020
Introduction Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has presented health-care systems worldwide with novel challenges and experiences and evidence is emerging during the pandemic. Patients requiring hospitalization frequently suffer
Klaus Nielsen Jeschke   +6 more
doaj   +1 more source

Immune Response to SARS-CoV-2 Vaccines

open access: yesBiomedicines, 2022
COVID-19 vaccines have been developed to confer immunity against the SARS-CoV-2 infection. Prior to the pandemic of COVID-19 which started in March 2020, there was a well-established understanding about the structure and pathogenesis of previously known ...
Navya Bellamkonda   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy